Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 729 evidences · page 15 / 70

48,7 %48.7% of individuals felt ashamed or condemned because of their situation.

NigeriaVIH/sidapublié 2026Scientific reportsPubMeddocument de 6 observations

47,1 %47.1% of inmates in Bauchi Prison had good knowledge of HIV/AIDS.

NigeriaVIH/sidapublié 2023The Pan African medical journalPubMeddocument de 5 observations

Optic nerve sheath diameter values among HIV-positive patients on HAART are significantly higher among female subjects.

NigeriaVIH/sidaobservé October 2017 to June 2018publié 2019Nigerian journal of clinical practicePubMeddocument de 5 observations

90,3 %In 2019, 90.3% of pregnant women receiving antenatal care in Nigeria were screened for HIV.

NigeriaVIH/sidaobservé 2019publié 2021International journal of STD & AIDSPubMeddocument de 10 observations

2 000 000 inhabitantsNigeria had nearly two million people living with HIV in 2021.

NigeriaVIH/sidaobservé 2021publié 2023Frontiers in public healthPubMeddocument de 9 observations

56,2 %The seroprevalence of herpes simplex virus (HSV)-2 among patients with HIV in Nigeria was 56.2%.

Nigeriaherpes simplex virus (HSV)-2 · VIH/sidaobservé 2019publié 2023BMJ openPubMeddocument de 5 observations

Sexual and gender minority people in Nigeria experience an HIV prevalence four to ten times higher than the national average.

NigeriaVIH/sidapublié 2026AIDS and behaviorPubMeddocument de 2 observations

56 %Some of the primary reasons for loss to follow-up were long distance to clinic (56%) and feeling healthy (6.7%).

NigeriaVIH/sidapublié 2019PloS onePubMeddocument de 8 observations

10 %Oral thrush was more prevalent in HAART-naïve patients (10%).

NigeriaVIH/sidapublié 2021Cardiovascular journal of AfricaPubMeddocument de 9 observations

28,8 %A weighted HIV prevalence of 28.8% was found among transgender populations in Nigeria.

NigeriaVIH/sidaobservé 2020publié 2025Sexually transmitted infectionsPubMeddocument de 12 observations

4 %An impaired relaxation pattern was observed in 4.0% of the HIV group.

NigeriaVIH/sidapublié 2022BMC pediatricsPubMeddocument de 6 observations

81 %Cross-resistance to at least one of the newer NNRTIs—doravirine, etravirine or rilpivirine—was predicted in 81% of participants with HIV-1 who had failed first-line ART in Nigeria.

NigeriaVIH/sidapublié 2022The Journal of antimicrobial chemotherapyPubMeddocument de 9 observations

68 %In a single-arm trial, self-reported adherence ≥90% among youth with HIV in Nigeria increased to 68% at 48 weeks (P = 0.031) compared with baseline.

NigeriaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 12 observations

81,3 %Among 370 HIV-positive individuals in Akwa Ibom state, Nigeria, 81.3% were not virally suppressed in 2017.

NigeriaVIH/sidaobservé 2017publié 2021Journal of the International AIDS SocietyPubMeddocument de 9 observations

7,2 %Forty-nine (7.2%) of 676 tuberculosis patients at the TB DOTS clinic of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, from January 2017 to December 2021 had unknown HIV status.

NigeriaVIH/sidaobservé 2017 to 2021publié 2024West African journal of medicinePubMeddocument de 14 observations

39,6 %Less than half of the participants strongly agreed that healthcare workers could provide post-exposure prophylaxis (PEP) to prevent human immunodeficiency virus (HIV) (39.6%).

NigeriaVIH/sidapublié 2025BMC women's healthPubMeddocument de 7 observations

28,5 %The rate of hearing loss among newly diagnosed HAART naive adult patients was 28.5%.

NigeriaVIH/sidaobservé July, 2018 to January, 2019publié 2022Nigerian journal of clinical practicePubMeddocument de 5 observations

63,6 %The seroprevalence of herpes simplex virus (HSV)-2 was 63.6% among married patients with HIV in Nigeria.

Nigeriaherpes simplex virus (HSV)-2 · VIH/sidaobservé 2019publié 2023BMJ openPubMeddocument de 5 observations

99,6 %CCSAPs achieved a viral load suppression rate of 99.6%.

NigeriaVIH/sidaobservé May 2022 to May 2023publié 2026BMC public healthPubMeddocument de 9 observations

Significant increases in alpha-1 and alpha-2 globulin concentrations were observed in the mono- and co-infected groups compared to the seronegative control group.

Nigeriahépatite B · VIH/sidapublié 2022African health sciencesPubMeddocument de 3 observations

22 USDThe unit cost per female sex worker tested for HIV was 22 USD.

NigeriaVIH/sidaobservé 2016publié 2023PloS onePubMeddocument de 10 observations

1,5 %The proportion with HIV was 1.5% among participants with history of tattoo/body incision.

NigeriaVIH/sidapublié 2022Journal of immunoassay & immunochemistryeurope_pmcdocument de 5 observations

63 %The contribution from community-based modalities to children living with HIV identified increased from 63% to 84% during the implementation period.

NigeriaVIH/sidapublié 2023BMC pediatricsPubMeddocument de 10 observations

78 %Among women living with HIV during their perinatal period in Ibadan, Nigeria, 78.0% reported perceived stress.

NigeriaVIH/sidaobservé 2022publié 2023Frontiers in public healthPubMeddocument de 3 observations

62 %The majority of participants (62%) were virally suppressed.

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 8 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.